CONDOR CAPITAL MANAGEMENT - REXAHN PHARMACEUTICALS INC ownership

REXAHN PHARMACEUTICALS INC's ticker is RNN and the CUSIP is 761640101. A total of 36 filers reported holding REXAHN PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
CONDOR CAPITAL MANAGEMENT ownership history of REXAHN PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2016$30,000
-16.7%
145,0000.0%0.01%
-22.2%
Q2 2016$36,000
-25.0%
145,0000.0%0.01%
-25.0%
Q1 2016$48,000
-56.4%
145,000
-31.4%
0.01%
-58.6%
Q3 2015$110,000
-14.1%
211,3710.0%0.03%
-6.5%
Q2 2015$128,000
-16.9%
211,3710.0%0.03%
-16.2%
Q1 2015$154,000
+81.2%
211,371
+74.2%
0.04%
+60.9%
Q4 2014$85,000
-41.4%
121,324
-32.1%
0.02%
-42.5%
Q3 2014$145,000
+45.0%
178,691
+55.4%
0.04%
+42.9%
Q2 2014$100,000114,9870.03%
Other shareholders
REXAHN PHARMACEUTICALS INC shareholders Q1 2016
NameSharesValueWeighting ↓
Northeast Financial Consultants Inc 150,000$109,0000.05%
CONDOR CAPITAL MANAGEMENT 211,371$154,0000.04%
Benin Management CORP 83,000$61,0000.03%
First Heartland Consultants, Inc. 20,000$15,0000.01%
Advisory Services Network, LLC 22,000$16,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 180,000$131,0000.00%
Moors & Cabot, Inc. 11,000$7,0000.00%
TCI Wealth Advisors, Inc. 3,000$2,0000.00%
Corbenic Partners LLC 1,600$1,0000.00%
WFG Advisors, LP 3,500$3,0000.00%
View complete list of REXAHN PHARMACEUTICALS INC shareholders